Minireviews
Copyright ©The Author(s) 2015.
World J Gastroenterol. Aug 28, 2015; 21(32): 9526-9533
Published online Aug 28, 2015. doi: 10.3748/wjg.v21.i32.9526
Table 2 Studies of interferon-free regimens for treatment of hepatitis C virus positive liver transplant candidates
Ref.No. of patientsSeverity of liver disease based on CP scoreAntiviral scheme (duration)Virological response
Curry et al[16]61 ≤ 7SOF + RBV (for 48 wk or until LT)69% (12 wk after LT)
Afdhal et al[17]405-10SOF + RBV (48 wk)100% and 93% for Child class A and B, respectively at 24 wk under treatment
Gane et al[18]207-9SOF + Ledipasvir ± RBV(12 wk)89%
Flamm et al[19]108Decompensated cirrhosis (CP score range: 7-12)Ledipasvir/SOF + RBV(12 or 24 wk)87% and 89% (for 12 and 24 wk, respectively)